Digital Psychosocial Interventions on Stigma and Health Outcomes in TB Patients
The Impact of Digital Psychosocial Interventions on Stigma and Health Outcomes in Tuberculosis Patients
1 other identifier
interventional
496
0 countries
N/A
Brief Summary
This study addresses the shortcomings of routine clinical management for tuberculosis (TB) patients by proposing psychosocial interventions targeting stigma, while investigating the current status of stigma, psychological issues, medication adherence, and drug resistance among tuberculosis patients. It analyzes the underlying mechanisms, integrates online mindfulness courses, digital cognitive behavioral therapy (CBT), and human-machine interactive dialogue modules to develop a digital psychosocial intervention platform. Through a randomized controlled trial, the study validates the impact of the platform on stigma and health outcomes among tuberculosis patients in China. Ultimately, the research aims to formulate a scalable digital psychosocial intervention technical solution, providing evidence-based support for optimizing China's comprehensive tuberculosis prevention and control model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2026
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
Study Completion
Last participant's last visit for all outcomes
December 1, 2028
August 3, 2026
April 1, 2026
11 months
July 27, 2026
July 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stigma: Tuberculosis-related Stigma Scale (TSS)
The tuberculosis-related stigma scale (TSS) was adopted in this study to quantitatively assess the level of tuberculosis-related stigma among participants.The scale consists of 9 items in total with a total score range of 0 to 27 points. Higher scores on the TSS indicate a more severe level of tuberculosis-related stigma.
Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention
Secondary Outcomes (3)
Mental Health, such as depression (Patient Health Questionnaire, PHQ-9)and anxiety (Generalized Anxiety Disorder Questionnaire, GAD-7)
Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention
Health outcomes, such as sputum conversion rate and quality of life (EuroQol 5 Dimensions,EQ-5D)
Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention
Medication Adherence (8-item Morisky Medication Adherence Scale, MMAS-8)
Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention
Other Outcomes (1)
Intervention adherence and acceptability
Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention
Study Arms (4)
Online Mindfulness Intervention Group
EXPERIMENTALParticipants in this group received a 6-week online mindfulness course delivered twice weekly.
Online CBT Intervention Group
EXPERIMENTALParticipants in this group received a 6-week online CBT intervention course delivered twice weekly.
Human-computer Interaction Intervention Group
EXPERIMENTALThe patients in this group are required to use the human-computer interaction system developed by our research institute for a duration of 6 weeks, with a frequency of no less than 2 use per week and a duration of no less than 20 minutes per use.
Control Group
ACTIVE COMPARATORPatients in the control group continued to receive routine treatment and management services provided by the tuberculosis prevention and control system throughout the study period. No additional psychosocial services or digital health services were offered beyond routine psychological support.
Interventions
The 6-week online mindfulness course developed by our research team consists of theoretical lectures plus practice audio and video materials, with 2 sessions delivered per week.
The 6-week online cbt course developed by our research team consists of 12 video materials, with 2 sessions delivered per week.
The human-computer interaction mini-program named Xiexin Xiangban, developed by the research team.
routine treatment and management services provided by the tuberculosis prevention and control system
Eligibility Criteria
You may qualify if:
- Aged 18 years or older.
- Patients diagnosed with active pulmonary tuberculosis within the past 1 year via bacteriological tests (smear microscopy or culture) and/or molecular biological assays (e.g., GeneXpert).
- Capable of independently completing questionnaires and scale assessments; accessible for sputum collection, chest radiography, biomarker testing and other examinations.
- Provided full informed consent for the entire study and signed the written informed consent form.
You may not qualify if:
- Presence of severe chronic diseases such as immune system disorders, or severe neurological and psychiatric disorders.
- No access to electronic devices required for subsequent online intervention.
- Cognitive impairment or hearing loss that impairs normal communication and prevents cooperation with surveys and intervention procedures.
- Concurrent participation in other health promotion or clinical intervention studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D. candidate
Study Record Dates
First Submitted
July 27, 2026
First Posted
August 3, 2026
Study Start (Estimated)
October 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
August 3, 2026
Record last verified: 2026-04